Funded startups/Verra Therapeutics, Inc.

Verra Therapeutics, Inc.

SEC filing

Biotechnology · Lansing, NY

Form D on EDGAR

Amount raised$205Ksold at filing

Total offering$450K$245K still open

Investors in the raise6count reported to the SEC

FiledFeb 18, 2026first sale Dec 16, 2024

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Jeffrey Lucas CalkinsDirector

Christopher Lucas PrinceExecutive Officer

Christopher Lucas PrinceDirector

Executive officers, directors and promoters as listed on the Form D.